Superfluid Dx

Superfluid Dx is revolutionizing the way Alzheimer's disease is diagnosed. Superfluid is building a translational science and data analytics platform that harnesses the power of cell-free mRNA to diagnose neurodegenerative diseases and other conditions. Headquartered in South San Francisco, Superfluid is led and funded by prominent figures in the life sciences, technology, and investment sectors.